Latest stories on NCEL
NewcelX to divest legacy Mazindol portfolio for up to $55M in milestones
The Fly58 · neutralm&a
NewcelX Enters Binding Term Sheet to Divest Mazindol Portfolio
TipRanks58 · neutralm&a
NewCelX Management to Attend Breakthrough T1D Congress in Philadelphia, Advancing Its Mission to Develop a Cure for Type 1 Diabetes
Business Insider63 · neutralproduct/pr
NLS Pharmaceutics GAAP EPS of -$0.96
Seeking Alpha28 · bearishearnings
NewcelX registers to sell 694K common shares for holders
The Fly28 · bearishgeneral
NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing
Business Insider28 · bearishgeneral
NewcelX Announces Pricing of $1.4 Million Equity Financing at 20% Premium Pricing
StockTitan28 · bearishgeneral
NewcelX Strengthens Diabetes Push With Appointment of Leading Transplant Pioneer Camillo Ricordi
TipRanks67 · bullishproduct/pr
NewcelX Stem Cell Platform Strengthened by Peer-Reviewed AstroRx Study in Multiple Sclerosis
TipRanks67 · bullishproduct/pr
NewcelX Files Pre-IND With FDA for NCEL-101 Type 1 Diabetes Cell Therapy
TipRanks63 · neutralproduct/pr
NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes | NCEL Stock News
StockTitan63 · neutralproduct/pr